mamaru engda getinet

Dr. mamaru engda getinet

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
MGmamaru engda getinet
mamaru engda getinet
MTMolla Taye
Molla Taye
AAAbebe Ayinalem
Abebe Ayinalem
MGMenberesibhat Gitie
Menberesibhat Gitie
Background: Cervical cancer is the commonest cancer of women’s reproductive system, and is caused by a progression of precancerous lesions of the cervix. Studies on the prevalence and associated factors of precancerous lesions of the cervix are very limited in Ethiopia, particularly in the study area. Objective: This study aimed to assess precancerous lesions of the cervix and associated factors among women of East Gojjam, northwest Ethiopia in 2020. Methods: A facility-based cross-sectional study was conducted on 340 cervical cancer–screened women in three hospitals of East Gojjam from February to April 2020. Data were collected by six BSc-qualified nurses who were working in the selected hospitals. EpiData Manager and SPSS 26 were used for data management and analysis. After the data had been clean, descriptive analysis was done and multivariate logistic regression used to identify predictors of precancerous lesions of the cervix. Statistical significance was taken to be P< 0.05. Results: Of the 340 recruited women, 15.3% (95% CI 11.83%– 19.54%) had precancerous cervical lesions. Mean age was 37.11± 9.3 years. Age 46– 55 (AOR 3.8, 95% CI 1.21– 12.47) years, age 56– 65 (AOR 12.26, 95% CI 3.18– 47.18) years, residing rurally (AOR 2.04, 95% CI 1.12– 3.7), prolonged use of oral contraceptive pills (AOR 9.11, 95% CI 1.14– 72.8), history of sexual transmitted infection (STI; AOR 3.40, 95% CI 1.32– 8.78), HIV-positive status (AOR 4.89, 95% CI 1.54– 15.49), and number of lifetime sexual partners (AOR 9.87, 95% CI 1.38– 70.4) were important factors associated with precancerous lesions of the cervix. Conclusion: We found relatively high prevalence of precancerous cervical lesions. Age, rural residence, prolonged use of oral contraceptives, STI, multiple sexual partners, and being HIV-positive were important factors associated with precancerous cervical lesions. Women aged > 46 years, with a history of STI, being HIV infected, and with a history of multiple sexual partners should be encouraged to get screened for cervical cancer.

1 January 2024 in AIDS Research and Treatment
Verified
Journal Article
Open access
MJMohammed Jemal
Mohammed Jemal
AAAdane Adugna
Adane Adugna
MGmamaru engda getinet
mamaru engda getinet
TBTemesgen Baylie
Temesgen Baylie
NWNuredin Chura Waritu
Nuredin Chura Waritu
Background: Overweight and obesity have arisen as major public health challenges, affecting not just the general population but also people living with human immunodeficiency virus (HIV) (PLWH). Obesity and being overweight are both risk factors for heart disease and other related complications. However, little is known in our setting. As a result, this study was conducted to evaluate the prevalence of overweight and obesity and its associated factors among PLWH on dolutegravir (DTG)‐ and efavirenz (EFV)‐based therapies.Methods: An institution‐based comparative cross‐sectional study was carried out from June 30, 2021, to August 30, 2021. We purposively recruited 128 participants who have been on DTG (n = 64)‐ and EFV (n = 64)‐based regimens for ≥ 6 months. Demographic, anthropometric, laboratory, and clinical data were collected using a structured questionnaire. The data were entered into EpiData Version 4.6 and analyzed using SPSS Version 26.0. Multivariable logistic regression was utilized to identify the factors that are associated with being overweight or obese, and the significance level was set at p < 0.05.Result: The prevalence of overweight and obesity was 28.1% in the DTG‐prescribed participants and 15.6% in the EFV‐prescribed participants. Age ≥ 40 years (adjusted odd ratio (AOR) = 3.86; 95% confidence interval (CI): 1.08–13.73; and p = 0.037), cluster of differentiation 4 (CD4) T‐cell counts ≥ 500 cells/mm3 (AOR = 2.95; 95% CI: 1.01–8.59; and p = 0.029), and insufficient physical activity (AOR = 4.6; 95% CI: 1.53–13.84; and p = 0.007) were predictors of overweight and obesity.Conclusion: Overweight and obesity are not uncommon among PLWH on ART. While the difference was statistically insignificant, the prevalence of overweight and obesity was higher in patients treated with DTG compared with those treated with EFV. Older age, higher CD4 cell counts, and insufficient physical activity were associated with overweight and obesity. As a result, healthcare providers must understand the health implications of obesity and consider incorporating targeted weight control programs into standard HIV treatment.

6 July 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MGmamaru engda getinet
mamaru engda getinet
MJMohammed Jemal
Mohammed Jemal
TBTemesgen Baylie
Temesgen Baylie
BWBayu Wendmneh
Bayu Wendmneh
GBGelagay Baye
Gelagay Baye
HBHabtamu Belew
Habtamu Belew
Objective This study aimed to assess high-risk human papillomavirus (HPV) infection (HPV 16/18) and its determinants among women in East Gojjam Zone, Northwest Ethiopia. Design An institutional-based cross-sectional study. Setting and participants The study was conducted among 337 women screened for cervical cancer in two hospitals in East Gojjam Zone from February to April 2021 gregoriean calander. Results The prevalence of HPV infection was 14.2% (95% CI: 10.7% to 18.1%). The mean age of the respondents was 36.7±9.1 years. Women in the age group of 55–65 years (adjusted OR (AOR)=7.91, 95% CI: 1.95 to 32.09), early initiation of sexual intercourse (AOR=5.36, 95% CI: 1.58 to 18.13), history of sexually transmitted infection (STI) (AOR=3.52, 95% CI: 1.27 to 9.72), HIV positive status (AOR=6.8, 95% CI: 1.99 to 23.54) and number of lifetime sexual partners (AOR=4.37, 95% CI: 1.15 to 17.3) were important independent factors associated with the presence of oncogenic HPV infection. Conclusion and recommendation We found a relatively low prevalence of high-risk HPV infection. Age, early initiation of sexual intercourse at less than 18 years, history of STI, being HIV seropositive and multiple sexual partners were important factors for high-risk HPV infection. Women aged >46 years, women with early initiation of sex, a history of STI, being HIV positive and a history of multiple sexual partners should be encouraged to be screened and vaccinated for HPV infection. Wider-ranging studies are also needed in HPV-infected women in association with the cervical lesion.

1 January 2025 in AIDS Research and Treatment
Verified
Journal Article
Open access
MJMohammed Jemal
Mohammed Jemal
AAAdane Adugna
Adane Adugna
MGmamaru engda getinet
mamaru engda getinet
BABaye Ashenef
Baye Ashenef
GBGelagey Baye
Gelagey Baye
EMEnyew Fenta Mengistu
Enyew Fenta Mengistu
Background: Dyslipidemia is a prevalent public health concern among individuals living with HIV who are undergoing antiretroviral therapy (ART), and it increases the risk of cardiovascular diseases. Despite the introduction of improved medications like dolutegravir, there are limited data regarding the extent of dyslipidemia in this population. Therefore, the purpose of this study was to determine the prevalence of dyslipidemia and its associated factors among people living with HIV on dolutegravir‐based ART. Methods: An institutional‐based cross‐sectional study was carried out from December 1, 2021, to February 30, 2022. Sociodemographic, behavioral, clinical, anthropometric, and laboratory data were collected from 423 participants. Simple random sampling methods were used to recruit the participants. The collected data were entered in Epi‐data Version 4.6 and analyzed via SPSS Version 26. Multivariable logistic regression was used to determine factors associated with dyslipidemia. A p value of < 0.05 was considered statistically significant. Results: The prevalence of dyslipidemia was found to be 73.8%. Low HDL‐C was the most common (61.2%), followed by elevated levels of TG (40.2%), high LDL‐C (26%), and high TC (24.3%). Being female (AOR = 1.77, 95% CI: 1.04–3.02, p = 0.034), insufficient physical activity (AOR = 1.64, 95% CI: 1–2.67, p = 0.048), being overweight (AOR = 2.25, 95% CI: 1.07–4.75, p = 0.033), and being obese (AOR = 2.32, 95% CI: 0.86–6.25, p = 0.045) were significantly associated with dyslipidemia. Conclusion: The prevalence of dyslipidemia among people living with HIV on a dolutegravir‐based ART was high, occurring in nearly three‐quarters of the participants. Being female, insufficient physical activity, and being overweight or obese were significantly associated with dyslipidemia among people living with HIV taking dolutegravir‐based ART. Therefore, to avoid the disastrous effects of dyslipidemia, serum lipid profiles should be considered and evaluated in people living with HIV on a dolutegravir‐based ART.

21 January 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
BMBirhanu Malede
Birhanu Malede
GAGashaw Azanaw Amare
Gashaw Azanaw Amare
ASAbebaw Setegn
Abebaw Setegn
ANAbebe Fenta Niguse
Abebe Fenta Niguse
AMAbeba Mengist
Abeba Mengist
YWYenesew Mihret Wondmagegn
Yenesew Mihret Wondmagegn
Malaria is a significant public health concern, particularly in endemic regions. Asymptomatic blood donors pose a risk for transfusion-transmitted malaria,

26 December 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MGmamaru engda getinet
mamaru engda getinet
Background: Human papillomavirus is a common pathogen that infects the skin and mucosal epithelium, is transmitted sexually; causes condylomas or squamous cell carcinomas. Two (16 and 18) of the 150 HPV serotypes are oncogenic types. Studies have been done on the infection by oncogenic human papillomavirus 16/18 and associated factors are found to be very limited in Ethiopia. Objective: This study aimed to assess the prevalence of oncogenic human papillomavirus infection (HPV 16/18) and associated factors among women. Methods: An institutional-based cross-sectional study was conducted among 337 women screened for cervical cancer in two hospitals in East Gojjam Zone from February to April 2021 G.C. Four BSc-qualified nurses who worked in the chosen hospitals collected the data using pretested questionnaire and an HPV test (OncoE6TM Cervical Test) specific to HPV16/18 in cervical swabs. Descriptive analysis was performed to determine the prevalence and a multivariate logistic regression model was used to identify the associated factors of HPV16/18 infection. Finally, statistical significance was declared at P < 0.05.Results: The prevalence of HPV infection was 14.2% (95% CI: 10.7% -18.1%). The mean age of the respondents was 36.7±9.1 years. Women with the age group of 55-65 years (AOR = 7.91, 95% CI: 1.95-32.09), early initiation of sexual intercourse (AOR = 5.36, 95% CI: 1.58-18.13), history of sexually transmitted infection (STI) (AOR = 3.52, 95% CI: 1.27-9.72), human immunodeficiency virus (HIV) positive status (AOR = 6.8, 95% CI: 1.99-23.54), and number of lifetime sexual partners (AOR = 4.37, 95% CI: 1.15-17.3) were important independent factors associated with the presence of oncogenic HPV infection. Conclusion and Recommendation: We found a relatively low prevalence of high-risk HPV infection. Age, early initiation of sexual intercourse at less than 18 years, STI of women, being HIV seropositive, and a number of sexual partners were important factors for high-risk HPV infection. Women aged > 46 years, women with early initiation of sex, a history of STI, being HIV positive, and a history of multiple sexual partners should be encouraged to be screened and vaccinated for HPV infection. Wider-ranging studies are also needed in HPV-infected women in association with the cervical lesion.